Female, n = 655 | Male, n = 652 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
T&CM, n = 242 | % | No T&CM, n = 413 | % | p-value | T&CM n = 166 | % | No T&CM n = 486 | % | p-value | |
Self-reported health | 0.038 | 0.341 | ||||||||
Medium to good | 217 | 88.8 | 386 | 93.5 | 157 | 94.6 | 449 | 92.4 | ||
Poor | 27 | 11.2 | 27 | 6.5 | 9 | 5.4 | 37 | 7.6 | ||
Cancer site first diagnosis | 0.876 | 0.954 | ||||||||
Breast | 98 | 40.5 | 164 | 39.7 | - | - | ||||
Female genital organs | 32 | 13.2 | 73 | 17.7 | - | - | ||||
Prostate | - | - | 74 | 44.6 | 212 | 43.6 | ||||
Other male genital organs | - | - | 14 | 8.4 | 35 | 7.2 | ||||
Respiratory organs | 7 | 2.9 | 11 | 2.7 | 2 | 1.2 | 11 | 2.3 | ||
Melanoma and skin | 24 | 9.9 | 36 | 8.7 | 18 | 10.8 | 49 | 10.1 | ||
Colon | 16 | 6.6 | 31 | 7.5 | 13 | 7.8 | 39 | 8.0 | ||
Other digestive organs | 12 | 5.0 | 19 | 4.6 | 11 | 6.6 | 30 | 6.2 | ||
Hematologic* | 14 | 5.8 | 23 | 5.6 | 11 | 6.6 | 45 | 9.3 | ||
Other cancers | 39 | 16.1 | 56 | 13.6 | 23 | 13.9 | 65 | 13.4 | ||
Breast cancer | 0.843 | |||||||||
Breast | 98 | 40.5 | 144 | 39.7 | ||||||
Other sites | 144 | 59.5 | 249 | 60.3 | ||||||
Prostate cancer | 0.830 | |||||||||
Prostate | 74 | 44.6 | 212 | 43.6 | ||||||
Other sites | 92 | 55.4 | 274 | 56.1 | ||||||
Metastasis at first diagnosis | 0.254 | 0.680 | ||||||||
Metastasis | 71 | 34.1 | 104 | 30.1 | 38 | 27.5 | 121 | 30.4 | ||
No metastasis | 136 | 65.4 | 242 | 69.9 | 100 | 72.5 | 276 | 69.3 | ||
Unknown | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 1 | 0.3 | ||
Time since first cancer diagnosis | 0.002 | 0.703 | ||||||||
less than a year | 21 | 8.7 | 29 | 7.0 | 17 | 10.2 | 50 | 10.3 | ||
1–5 years | 100 | 41.3 | 118 | 28.6 | 67 | 40.4 | 200 | 41.2 | ||
6–10 years | 48 | 19.8 | 87 | 21.1 | 38 | 22.9 | 92 | 18.9 | ||
more than 10 years | 73 | 30.2 | 179 | 43.3 | 44 | 26.5 | 144 | 29.6 | ||
Number of cancer diagnoses | 0.132 | 0.303 | ||||||||
Cancer once | 209 | 86.4 | 338 | 81.8 | 137 | 82.5 | 383 | 78.8 | ||
Cancer twice or more times | 33 | 13.6 | 75 | 18.2 | 29 | 17.5 | 103 | 21.2 | ||
Only one treatment modality | 0.372 | .5591 | ||||||||
Surgery | 28 | 27.2 | 45 | 31.3 | 26 | 55.3 | 85 | 55.6 | ||
CT | 12 | 11.7 | 18 | 12.5 | 7 | 14.9 | 20 | 13.1 | ||
RT | 60 | 58.3 | 71 | 49.3 | 11 | 23.4 | 44 | 28.8 | ||
HT | 3 | 2.9 | 10 | 6.9 | 3 | 6.4 | 4 | 2.6 | ||
Multimodal treatment | ||||||||||
Surgery and CT | 58 | 24.0 | 121 | 29.3 | 0.140 | 49 | 29.5 | 144 | 29.6 | 0.978 |
Surgery and RT | 112 | 46.3 | 189 | 45.8 | 0.898 | 53 | 31.9 | 169 | 34.8 | 0.503 |
Surgery and HT | 38 | 15.7 | 101 | 24.5 | 0.008 | 32 | 19.3 | 103 | 21.1 | 0.599 |
CT and RT | 51 | 21.1 | 93 | 22.5 | 0.667 | 16 | 9.6 | 71 | 14.6 | 0.104 |
CT and HT | 43 | 17.8 | 75 | 18.2 | 0.900 | 15 | 9.0 | 60 | 12.3 | 0.249 |
Surgery, CT and HT | 59 | 24.4 | 113 | 27.4 | 0.403 | 34 | 20.5 | 116 | 23.9 | 0.371 |
CT, HT and RT | 52 | 21.5 | 94 | 22.8 | 0.706 | 17 | 10.2 | 73 | 15.0 | 0.123 |
Surgery, HT and RT | 41 | 16.9 | 106 | 25.7 | 0.010 | 34 | 20.5 | 112 | 23.0 | 0.494 |
Surgery, CT and RT | 61 | 25.2 | 119 | 28.8 | 0.318 | 34 | 20.5 | 122 | 251 | 0.228 |
Surgery, CT, RT and HT | 61 | 25.2 | 119 | 28.8 | 0.318 | 35 | 21.1 | 122 | 25.1 | 0.296 |